Identification of potential targets for differentiation in human leukemia cells induced by diallyl disulfide

Ling,Hui; He,Jie; Tan,Hui; Yi,Lan; Liu,Fang; Ji,Xiaoxia; Wu,Youhua; Hu,Haobin; Zeng,Xi; Ai,Xiaohong; Jiang,Hao; Su,Qi

doi:10.3892/ijo.2017.3839

Identification of potential targets for differentiation in human leukemia cells induced by diallyl disulfide

Authors:
- Hui Ling
- Jie He
- Hui Tan
- Lan Yi
- Fang Liu
- Xiaoxia Ji
- Youhua Wu
- Haobin Hu
- Xi Zeng
- Xiaohong Ai
- Hao Jiang
- Qi Su
View Affiliations

Affiliations: Key Laboratory of Tumor Cellular and Molecular Pathology, College of Hunan Province, Cancer Research Institute, University of South China, Hengyang, Hunan 421001, P.R. China, The First Affiliated Hospital, University of South China, Hengyang, Hunan 421001, P.R. China
Published online on: January 5, 2017 https://doi.org/10.3892/ijo.2017.3839
Pages: 697-707

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diallyl disulfide (DADS) is a primary component of garlic, which has chemopreventive potential. We previously found that moderate doses (15-120 µM) of DADS induced apoptosis and G2/M phase cell cycle arrest. In this study, we observed the effect of low doses (8 µM) of DADS on human leukemia HL-60 cells. We found that DADS could inhibit proliferation, migration and invasion in HL-60 cells, and arrested cells at G0/G1 stage. Then, cell differentiation was displayed by morphologic observation, NBT reduction activity and CD11b evaluation of cytometric flow. It showed that DADS induced differentiation, reduced the ability of NBT and increased CD11b expression. Likewise, DADS inhibited xenograft tumor growth and induced differentiation in vivo. In order to make sure how DADS induced differentiation, we compared the protein expression profile of DADS-treated cells with that of untreated control. Using high resolution mass spectrometry, we identified 18 differentially expressed proteins after treatment with DADS, including four upregulated and 14 downregulated proteins. RT-PCR and western blot assay showed that DJ-1, cofilin 1, RhoGDP dissociation inhibitor 2 (RhoGDI2), Calreticulin (CTR) and PCNA were decreased by DADS. These data suggest that the effects of DADS on leukemia may be due to multiple targets for intervention.

View Figures

View References

1	Schlenk RF: Post-remission therapy for acute myeloid leukemia. Haematologica. 99:1663–1670. 2014. View Article : Google Scholar : PubMed/NCBI
2	Mrózek K, Marcucci G, Nicolet D, Maharry KS, Becker H, Whitman SP, Metzeler KH, Schwind S, Wu YZ, Kohlschmidt J, et al: Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia. J Clin Oncol. 30:4515–4523. 2012. View Article : Google Scholar : PubMed/NCBI
3	Morceau F, Chateauvieux S, Orsini M, Trécul A, Dicato M and Diederich M: Natural compounds and pharmaceuticals reprogram leukemia cell differentiation pathways. Biotechnol Adv. 33:785–797. 2015. View Article : Google Scholar : PubMed/NCBI
4	Sui M, Zhang Z and Zhou J: Inhibition factors of arsenic trioxide therapeutic effects in patients with acute promyelocytic leukemia. Chin Med J (Engl). 127:3503–3506. 2014.
5	Gallagher RE: Retinoic acid resistance in acute promyelocytic leukemia. Leukemia. 16:1940–1958. 2002. View Article : Google Scholar : PubMed/NCBI
6	Sanz MA and Montesinos P: How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia. Blood. 123:2777–2782. 2014. View Article : Google Scholar : PubMed/NCBI
7	Kweon SH, Song JH, Kim HJ, Kim TS and Choi BG: Induction of human leukemia cell differentiation via PKC/MAPK pathways by arsantin, a sesquiterpene lactone from Artemisia santolina. Arch Pharm Res. 38:2020–2028. 2015. View Article : Google Scholar : PubMed/NCBI
8	Yi L and Su Q: Molecular mechanisms for the anticancer effects of diallyl disulfide. Food Chem Toxicol. 57:362–370. 2013. View Article : Google Scholar : PubMed/NCBI
9	Sundaram SG and Milner JA: Diallyl disulfide suppresses the growth of human colon tumor cell xenografts in athymic nude mice. J Nutr. 126:1355–1361. 1996.PubMed/NCBI
10	Yi L, Ji XX, Lin M, Tan H, Tang Y, Wen L, Ma YH and Su Q: Diallyl disulfide induces apoptosis in human leukemia HL-60 cells through activation of JNK mediated by reactive oxygen. Pharmazie. 65:693–698. 2010.PubMed/NCBI
11	Yi L, Ji XX, Tan H, Feng MY, Tang Y, Wen L and Su Q: Involvement of Mcl1 in diallyl disulfide-induced G2/M cell cycle arrest in HL-60 cells. Oncol Rep. 27:1911–1917. 2012.PubMed/NCBI
12	Gharahdaghi F, Weinberg CR, Meagher DA, Imai BS and Mische SM: Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: A method for the removal of silver ions to enhance sensitivity. Electrophoresis. 20:601–605. 1999. View Article : Google Scholar : PubMed/NCBI
13	Ling H, Zhang LY, Su Q, Song Y, Luo ZY, Zhou XT, Zeng X, He J, Tan H and Yuan JP: Erk is involved in the differentiation induced by diallyl disulfide in the human gastric cancer cell line MGC803. Cell Mol Biol Lett. 11:408–423. 2006. View Article : Google Scholar : PubMed/NCBI
14	Lai KC, Hsu SC, Kuo CL, Yang JS, Ma CY, Lu HF, Tang NY, Hsia TC, Ho HC and Chung JG: Diallyl sulfide, diallyl disulfide, and diallyl trisulfide inhibit migration and invasion in human colon cancer colo 205 cells through the inhibition of matrix metalloproteinase-2, -7, and -9 expressions. Environ Toxicol. 28:479–488. 2013. View Article : Google Scholar
15	Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Iguchi-Ariga SM and Ariga H: DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun. 231:509–513. 1997. View Article : Google Scholar : PubMed/NCBI
16	Zhou X, Xu N, Li R, Xiao Y, Gao G, Lu Q, Ding L, Li L, Li Y, Du Q, et al: A comparative proteomic study of Homoharringtonine-induced apoptosis in leukemia K562 cells. Leuk Lymphoma. 56:2162–2169. 2015. View Article : Google Scholar
17	Liu H, Wang M, Li M, Wang D, Rao Q, Wang Y, Xu Z and Wang J: Expression and role of DJ-1 in leukemia. Biochem Biophys Res Commun. 375:477–483. 2008. View Article : Google Scholar : PubMed/NCBI
18	Bai J, Guo C, Sun W, Li M, Meng X, Yu Y, Jin Y, Tong D, Geng J, Huang Q, et al: DJ-1 may contribute to metastasis of non-small cell lung cancer. Mol Biol Rep. 39:2697–2703. 2012. View Article : Google Scholar
19	Lee H, Choi SK and Ro JY: Overexpression of DJ-1 and HSP90α, and loss of PTEN associated with invasive urothelial carcinoma of urinary bladder: Possible prognostic markers. Oncol Lett. 3:507–512. 2012.PubMed/NCBI
20	Kim YC, Kitaura H, Taira T, Iguchi-Ariga SM and Ariga H: Oxidation of DJ-1-dependent cell transformation through direct binding of DJ-1 to PTEN. Int J Oncol. 35:1331–1341. 2009.PubMed/NCBI
21	Vasseur S, Afzal S, Tomasini R, Guillaumond F, Tardivel-Lacombe J, Mak TW and Iovanna JL: Consequences of DJ-1 upregulation following p53 loss and cell transformation. Oncogene. 31:664–670. 2012.
22	Zhou J, Wang Y, Fei J and Zhang W: expression of cofilin 1 is positively correlated with the differentiation of human epithelial ovarian cancer. Oncol Lett. 4:1187–1190. 2012.PubMed/NCBI
23	Harris W, Sachana M, Flaskos J and Hargreaves AJ: Proteomic analysis of differentiating neuroblastoma cells treated with sublethal neurite inhibitory concentrations of diazinon: Identification of novel biomarkers of effect. Toxicol Appl Pharmacol. 240:159–165. 2009. View Article : Google Scholar : PubMed/NCBI
24	Heasman SJ and Ridley AJ: Mammalian Rho GTPases: New insights into their functions from in vivo studies. Nat Rev Mol Cell Biol. 9:690–701. 2008. View Article : Google Scholar : PubMed/NCBI
25	Koh SA, Kim MK, Lee KH, Kim SW and Kim JR: RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer. Clin exp Metastasis. 31:805–815. 2014. View Article : Google Scholar : PubMed/NCBI
26	Fang Y, Yi J, Lizhi L and Qiucheng C: Rho GDP dissociation inhibitor beta promotes cell proliferation and invasion by modulating the AKT pathway in hepatocellular carcinoma. DNA Cell Biol. 33:781–786. 2014. View Article : Google Scholar : PubMed/NCBI
27	López-Pedrera C, Villalba JM, Siendones E, Barbarroja N, Gómez-Díaz C, Rodríguez-Ariza A, Buendía P, Torres A and Velasco F: Proteomic analysis of acute myeloid leukemia: Identification of potential early biomarkers and therapeutic targets. Proteomics. 6(Suppl 1): S293–S299. 2006. View Article : Google Scholar : PubMed/NCBI
28	Griner EM and Theodorescu D: The faces and friends of RhoGDI2. Cancer Metastasis Rev. 31:519–528. 2012. View Article : Google Scholar : PubMed/NCBI
29	Griner EM, Dancik GM, Costello JC, Owens C, Guin S, Edwards MG, Brautigan DL, Theodorescu D and Rho C: RhoC is an unexpected target of RhoGDI2 in prevention of lung colonization of bladder cancer. Mol Cancer Res. 13:483–492. 2015. View Article : Google Scholar :
30	Zamanian M, Veerakumarasivam A, Abdullah S and Rosli R: Calreticulin and cancer. Pathol Oncol Res. 19:149–154. 2013. View Article : Google Scholar : PubMed/NCBI
31	Weng WC, Lin KH, Wu PY, Lu YC, Weng YC, Wang BJ, Liao YF, Hsu WM, Lee WT and Lee H: Calreticulin regulates VEGF-A in neuroblastoma cells. Mol Neurobiol. 52:758–770. 2015. View Article : Google Scholar
32	Lu YC, Weng WC and Lee H: Functional roles of calreticulin in cancer biology. Biomed Res Int. 2015:5265242015. View Article : Google Scholar : PubMed/NCBI
33	Caputo E, Maiorana L, Vasta V, Pezzino FM, Sunkara S, Wynne K, Elia G, Marincola FM, McCubrey JA, Libra M, et al: Characterization of human melanoma cell lines and melanocytes by proteome analysis. Cell Cycle. 10:2924–2936. 2011. View Article : Google Scholar : PubMed/NCBI
34	Qin H, Liu T, Yang JL, Huang X, Liu B, Song X, Zhao X and Wei YQ: Screening proteins related to retinoic acid resistance by proteomic analysis. Zhonghua Yi Xue Za Zhi. 87:520–525. 2007.In Chinese. PubMed/NCBI
35	Wang SC: PCNA: A silent housekeeper or a potential therapeutic target? Trends Pharmacol Sci. 35:178–186. 2014. View Article : Google Scholar : PubMed/NCBI
36	Zhu Q, Chang Y, Yang J and Wei Q: Post-translational modifications of proliferating cell nuclear antigen: A key signal integrator for DNA damage response (Review). Oncol Lett. 7:1363–1369. 2014.PubMed/NCBI
37	Calaf GM, Echiburú-Chau C, Wen G, Balajee AS and Roy D: Effect of curcumin on irradiated and estrogen-transformed human breast cell lines. Int J Oncol. 40:436–442. 2012.